icone plus
Contact Abonnez-vous aux actualités
Reason for request
Re-assessment of the Actual Benefit
Clinical Benefit
Insufficient
The actual benefit of the proprietary medicinal product ROHYPNOL is insufficient in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia".
Therapeutic use
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
Edz6RpsP5PqqDDDz
Listen
